+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Dry Eye Syndrome Drugs Market 2023-2027

  • PDF Icon

    Report

  • 161 Pages
  • May 2023
  • Region: Global
  • TechNavio
  • ID: 5237577
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The dry eye syndrome drugs market is forecasted to grow by USD 2,159.21 mn during 2022-2027, accelerating at a CAGR of 6.53% during the forecast period. The report on the dry eye syndrome drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by a growing geriatric population, growing healthcare expenditure, and changing lifestyles and rising cases of diseases contributing to dry eye syndrome.

The dry eye syndrome drugs market is segmented as below:

By Distribution Channel

  • Retail pharmacies
  • Hospital pharmacies
  • Online pharmacies

By Product

  • OTC drugs
  • Prescription drugs

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the advancements in drug delivery technologies as one of the prime reasons driving the dry eye syndrome drugs market growth during the next few years. Also, advancements in diagnostic techniques for dry eye syndrome and the shift of dry eye syndrome drugs toward personalized medicine will lead to sizable demand in the market.

The report on the dry eye syndrome drugs market covers the following areas:

  • Dry eye syndrome drugs market sizing
  • Dry eye syndrome drugs market forecast
  • Dry eye syndrome drugs market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading dry eye syndrome drugs market vendors that include Abbott Laboratories, AbbVie Inc., AFT Pharmaceuticals Ltd., Akorn Operating Co. LLC, Bausch Health Co. Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, I MED Pharma Inc., Johnson and Johnson Services Inc., Laboratoires THEA SAS, Mitotech SA, Novaliq GmbH, Novartis AG, Oasis Medical Inc., Otsuka Holdings Co. Ltd., Santen Pharmaceutical Co. Ltd., Sentiss Pharma Pvt. Ltd., Sun Pharmaceutical Industries Ltd., Viatris Inc., and Visufarma. Also, the dry eye syndrome drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global dry eye syndrome drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global dry eye syndrome drugs market 2017 - 2021 ($ million)
4.2 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.3 Product Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Distribution Channel
6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Retail pharmacies - Market size and forecast 2022-2027
Exhibit 34: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
6.4 Hospital pharmacies - Market size and forecast 2022-2027
Exhibit 38: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
6.5 Online pharmacies - Market size and forecast 2022-2027
Exhibit 42: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Distribution Channel
Exhibit 46: Market opportunity by Distribution Channel ($ million)
Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)
7 Market Segmentation by Product
7.1 Market segments
Exhibit 48: Chart on Product - Market share 2022-2027 (%)
Exhibit 49: Data Table on Product - Market share 2022-2027 (%)
7.2 Comparison by Product
Exhibit 50: Chart on Comparison by Product
Exhibit 51: Data Table on Comparison by Product
7.3 OTC drugs - Market size and forecast 2022-2027
Exhibit 52: Chart on OTC drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on OTC drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on OTC drugs - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on OTC drugs - Year-over-year growth 2022-2027 (%)
7.4 Prescription drugs - Market size and forecast 2022-2027
Exhibit 56: Chart on Prescription drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Prescription drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Prescription drugs - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Prescription drugs - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Product
Exhibit 60: Market opportunity by Product ($ million)
Exhibit 61: Data Table on Market opportunity by Product ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 Japan - Market size and forecast 2022-2027
Exhibit 91: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.10 Germany - Market size and forecast 2022-2027
Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 111: Abbott Laboratories - Overview
Exhibit 112: Abbott Laboratories - Business segments
Exhibit 113: Abbott Laboratories - Key news
Exhibit 114: Abbott Laboratories - Key offerings
Exhibit 115: Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
Exhibit 116: AbbVie Inc. - Overview
Exhibit 117: AbbVie Inc. - Product/Service
Exhibit 118: AbbVie Inc. - Key news
Exhibit 119: AbbVie Inc. - Key offerings
12.5 AFT Pharmaceuticals Ltd.
Exhibit 120: AFT Pharmaceuticals Ltd. - Overview
Exhibit 121: AFT Pharmaceuticals Ltd. - Business segments
Exhibit 122: AFT Pharmaceuticals Ltd. - Key offerings
Exhibit 123: AFT Pharmaceuticals Ltd. - Segment focus
12.6 Bausch Health Co. Inc.
Exhibit 124: Bausch Health Co. Inc. - Overview
Exhibit 125: Bausch Health Co. Inc. - Business segments
Exhibit 126: Bausch Health Co. Inc. - Key news
Exhibit 127: Bausch Health Co. Inc. - Key offerings
Exhibit 128: Bausch Health Co. Inc. - Segment focus
12.7 I MED Pharma Inc.
Exhibit 129: I MED Pharma Inc. - Overview
Exhibit 130: I MED Pharma Inc. - Product/Service
Exhibit 131: I MED Pharma Inc. - Key offerings
12.8 Johnson and Johnson Services Inc.
Exhibit 132: Johnson and Johnson Services Inc. - Overview
Exhibit 133: Johnson and Johnson Services Inc. - Business segments
Exhibit 134: Johnson and Johnson Services Inc. - Key news
Exhibit 135: Johnson and Johnson Services Inc. - Key offerings
Exhibit 136: Johnson and Johnson Services Inc. - Segment focus
12.9 Laboratoires THEA SAS
Exhibit 137: Laboratoires THEA SAS - Overview
Exhibit 138: Laboratoires THEA SAS - Product/Service
Exhibit 139: Laboratoires THEA SAS - Key offerings
12.10 Mitotech SA
Exhibit 140: Mitotech SA - Overview
Exhibit 141: Mitotech SA - Product/Service
Exhibit 142: Mitotech SA - Key offerings
12.11 Novaliq GmbH
Exhibit 143: Novaliq GmbH - Overview
Exhibit 144: Novaliq GmbH - Product/Service
Exhibit 145: Novaliq GmbH - Key offerings
12.12 Novartis AG
Exhibit 146: Novartis AG - Overview
Exhibit 147: Novartis AG - Business segments
Exhibit 148: Novartis AG - Key offerings
Exhibit 149: Novartis AG - Segment focus
12.13 Oasis Medical Inc.
Exhibit 150: Oasis Medical Inc. - Overview
Exhibit 151: Oasis Medical Inc. - Product/Service
Exhibit 152: Oasis Medical Inc. - Key offerings
12.14 Otsuka Holdings Co. Ltd.
Exhibit 153: Otsuka Holdings Co. Ltd. - Overview
Exhibit 154: Otsuka Holdings Co. Ltd. - Business segments
Exhibit 155: Otsuka Holdings Co. Ltd. - Key offerings
Exhibit 156: Otsuka Holdings Co. Ltd. - Segment focus
12.15 Santen Pharmaceutical Co. Ltd.
Exhibit 157: Santen Pharmaceutical Co. Ltd. - Overview
Exhibit 158: Santen Pharmaceutical Co. Ltd. - Product/Service
Exhibit 159: Santen Pharmaceutical Co. Ltd. - Key offerings
12.16 Sun Pharmaceutical Industries Ltd.
Exhibit 160: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 161: Sun Pharmaceutical Industries Ltd. - Product/Service
Exhibit 162: Sun Pharmaceutical Industries Ltd. - Key offerings
12.17 Viatris Inc.
Exhibit 163: Viatris Inc. - Overview
Exhibit 164: Viatris Inc. - Business segments
Exhibit 165: Viatris Inc. - Key news
Exhibit 166: Viatris Inc. - Key offerings
Exhibit 167: Viatris Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 168: Inclusions checklist
Exhibit 169: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 170: Currency conversion rates for US$
13.4 Research methodology
Exhibit 171: Research methodology
Exhibit 172: Validation techniques employed for market sizing
Exhibit 173: Information sources
13.5 List of abbreviations
Exhibit 174: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 6: Executive Summary - Chart on Market Segmentation by Product
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global dry eye syndrome drugs market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Distribution Channel
Exhibits 33: Data Table on Comparison by Distribution Channel
Exhibits 34: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits 43: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits 44: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 46: Market opportunity by Distribution Channel ($ million)
Exhibits 47: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 48: Chart on Product - Market share 2022-2027 (%)
Exhibits 49: Data Table on Product - Market share 2022-2027 (%)
Exhibits 50: Chart on Comparison by Product
Exhibits 51: Data Table on Comparison by Product
Exhibits 52: Chart on OTC drugs - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Data Table on OTC drugs - Market size and forecast 2022-2027 ($ million)
Exhibits 54: Chart on OTC drugs - Year-over-year growth 2022-2027 (%)
Exhibits 55: Data Table on OTC drugs - Year-over-year growth 2022-2027 (%)
Exhibits 56: Chart on Prescription drugs - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Data Table on Prescription drugs - Market size and forecast 2022-2027 ($ million)
Exhibits 58: Chart on Prescription drugs - Year-over-year growth 2022-2027 (%)
Exhibits 59: Data Table on Prescription drugs - Year-over-year growth 2022-2027 (%)
Exhibits 60: Market opportunity by Product ($ million)
Exhibits 61: Data Table on Market opportunity by Product ($ million)
Exhibits 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 65: Chart on Geographic comparison
Exhibits 66: Data Table on Geographic comparison
Exhibits 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 103: Market opportunity By Geographical Landscape ($ million)
Exhibits 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 105: Impact of drivers and challenges in 2022 and 2027
Exhibits 106: Overview on Criticality of inputs and Factors of differentiation
Exhibits 107: Overview on factors of disruption
Exhibits 108: Impact of key risks on business
Exhibits 109: Vendors covered
Exhibits 110: Matrix on vendor position and classification
Exhibits 111: Abbott Laboratories - Overview
Exhibits 112: Abbott Laboratories - Business segments
Exhibits 113: Abbott Laboratories - Key news
Exhibits 114: Abbott Laboratories - Key offerings
Exhibits 115: Abbott Laboratories - Segment focus
Exhibits 116: AbbVie Inc. - Overview
Exhibits 117: AbbVie Inc. - Product/Service
Exhibits 118: AbbVie Inc. - Key news
Exhibits 119: AbbVie Inc. - Key offerings
Exhibits 120: AFT Pharmaceuticals Ltd. - Overview
Exhibits 121: AFT Pharmaceuticals Ltd. - Business segments
Exhibits 122: AFT Pharmaceuticals Ltd. - Key offerings
Exhibits 123: AFT Pharmaceuticals Ltd. - Segment focus
Exhibits 124: Bausch Health Co. Inc. - Overview
Exhibits 125: Bausch Health Co. Inc. - Business segments
Exhibits 126: Bausch Health Co. Inc. - Key news
Exhibits 127: Bausch Health Co. Inc. - Key offerings
Exhibits 128: Bausch Health Co. Inc. - Segment focus
Exhibits 129: I MED Pharma Inc. - Overview
Exhibits 130: I MED Pharma Inc. - Product/Service
Exhibits 131: I MED Pharma Inc. - Key offerings
Exhibits 132: Johnson and Johnson Services Inc. - Overview
Exhibits 133: Johnson and Johnson Services Inc. - Business segments
Exhibits 134: Johnson and Johnson Services Inc. - Key news
Exhibits 135: Johnson and Johnson Services Inc. - Key offerings
Exhibits 136: Johnson and Johnson Services Inc. - Segment focus
Exhibits 137: Laboratoires THEA SAS - Overview
Exhibits 138: Laboratoires THEA SAS - Product/Service
Exhibits 139: Laboratoires THEA SAS - Key offerings
Exhibits 140: Mitotech SA - Overview
Exhibits 141: Mitotech SA - Product/Service
Exhibits 142: Mitotech SA - Key offerings
Exhibits 143: Novaliq GmbH - Overview
Exhibits 144: Novaliq GmbH - Product/Service
Exhibits 145: Novaliq GmbH - Key offerings
Exhibits 146: Novartis AG - Overview
Exhibits 147: Novartis AG - Business segments
Exhibits 148: Novartis AG - Key offerings
Exhibits 149: Novartis AG - Segment focus
Exhibits 150: Oasis Medical Inc. - Overview
Exhibits 151: Oasis Medical Inc. - Product/Service
Exhibits 152: Oasis Medical Inc. - Key offerings
Exhibits 153: Otsuka Holdings Co. Ltd. - Overview
Exhibits 154: Otsuka Holdings Co. Ltd. - Business segments
Exhibits 155: Otsuka Holdings Co. Ltd. - Key offerings
Exhibits 156: Otsuka Holdings Co. Ltd. - Segment focus
Exhibits 157: Santen Pharmaceutical Co. Ltd. - Overview
Exhibits 158: Santen Pharmaceutical Co. Ltd. - Product/Service
Exhibits 159: Santen Pharmaceutical Co. Ltd. - Key offerings
Exhibits 160: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 161: Sun Pharmaceutical Industries Ltd. - Product/Service
Exhibits 162: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 163: Viatris Inc. - Overview
Exhibits 164: Viatris Inc. - Business segments
Exhibits 165: Viatris Inc. - Key news
Exhibits 166: Viatris Inc. - Key offerings
Exhibits 167: Viatris Inc. - Segment focus
Exhibits 168: Inclusions checklist
Exhibits 169: Exclusions checklist
Exhibits 170: Currency conversion rates for US$
Exhibits 171: Research methodology
Exhibits 172: Validation techniques employed for market sizing
Exhibits 173: Information sources
Exhibits 174: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global dry eye syndrome drugs market: Abbott Laboratories, AbbVie Inc., AFT Pharmaceuticals Ltd., Akorn Operating Co. LLC, Bausch Health Co. Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, I MED Pharma Inc., Johnson and Johnson Services Inc., Laboratoires THEA SAS, Mitotech SA, Novaliq GmbH, Novartis AG, Oasis Medical Inc., Otsuka Holdings Co. Ltd., Santen Pharmaceutical Co. Ltd., Sentiss Pharma Pvt. Ltd., Sun Pharmaceutical Industries Ltd., Viatris Inc., and Visufarma.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is advancements in drug delivery technologies.'

According to the report, one of the major drivers for this market is the growing geriatric population.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • AbbVie Inc.
  • AFT Pharmaceuticals Ltd.
  • Akorn Operating Co. LLC
  • Bausch Health Co. Inc.
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • I MED Pharma Inc.
  • Johnson and Johnson Services Inc.
  • Laboratoires THEA SAS
  • Mitotech SA
  • Novaliq GmbH
  • Novartis AG
  • Oasis Medical Inc.
  • Otsuka Holdings Co. Ltd.
  • Santen Pharmaceutical Co. Ltd.
  • Sentiss Pharma Pvt. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Visufarma

Related Topics

Related Reports

Dry Eye Syndrome Treatment Market By Drug, By Dosage form, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Image

Dry Eye Syndrome Treatment Market By Drug, By Dosage form, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • 235 Pages
  • Global
From
Global Dry Eye Syndrome Market by Drug (Anti-inflammatory Drugs, Autologous Serum Eye Drops, Lubricant Eye Drops), Product (Eye Ointment, Gel, Liquid Drops) - Forecast 2024-2030 - Product Image

Global Dry Eye Syndrome Market by Drug (Anti-inflammatory Drugs, Autologous Serum Eye Drops, Lubricant Eye Drops), Product (Eye Ointment, Gel, Liquid Drops) - Forecast 2024-2030

  • Report
  • 199 Pages
  • Global
From
Dry Eye Syndrome Market Report by Disease Type, Drug Type, Product, Distribution Channel, and Region 2024-2032 - Product Image

Dry Eye Syndrome Market Report by Disease Type, Drug Type, Product, Distribution Channel, and Region 2024-2032

  • Report
  • 144 Pages
  • Global
From
Dry Eye Medication Global Market Report 2024 - Product Image

Dry Eye Medication Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Global Dry Eye Syndrome Market Analysis & Forecast to 2023-2033: Market By Type; By Product; By Drug; By Dosage; By Distribution Channel; and By Region - Product Image

Global Dry Eye Syndrome Market Analysis & Forecast to 2023-2033: Market By Type; By Product; By Drug; By Dosage; By Distribution Channel; and By Region

  • Report
  • 145 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.